← All organizations

Karo Bio AB

For profit

Also known as: Karo Pharma AB

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 1, 2011

Timeline

1980s

Jun 1, 1987
Karo Bio AB— Founded

2010s

Apr 27, 2015
Tanomed AB— Acquired
Oct 2, 2015
Swereco— Acquired

Drugs by trial phase (2 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

eprotirome

Phase 2 (1 own, 0 via acquisition)

ezetimibe

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (6)

NCT01410383Lead sponsorPhase 3Oct 1, 2011
NCT00677248Study chairPhase 2Apr 1, 2008
NCT00677248Lead sponsorPhase 2Apr 1, 2008
NCT00593047Study directorPhase 2Nov 1, 2007
NCT00593047Lead sponsorPhase 2Nov 1, 2007
NCT00776321Lead sponsorPhase 2Sep 1, 2006

Details

Founded: Huddinge, SE Jun 1, 1987
Last known activity: Oct 1, 2011